Skin substitute grafts made from cellular and tissue-based products have helped to revolutionize chronic wound care, but federal regulators are greatly reducing coverage for Medicare beneficiaries.

The General Enrollment Period provides an opportunity to make up for a past oversight — the failure to enroll in Part B.

The Inflation Reduction Act (IRA), passed in 2022, made changes to the way drugs are covered and reimbursed in Medicare.

One of those orders directed the Center for Medicare and Medicaid Services ... limited model capping insulin costs at $35 per month for people on participating Medicare Part D prescription ...

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly ... can still visit today Oscars: Full List of Nominees Trump executive order ...

That report lists three proposed models: the Medicare High-Value Drug List Model, the Cell & Gene Therapy Access Model and the Accelerating Clinical Evidence Model. The first model allows Part D ...

The selected drugs treat conditions like diabetes, cancer and asthma WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- Medicare will soon negotiate prices for 15 more drugs as part of an effort to ...

The first proposed model encouraged sponsors of Medicare Part D ... Affordable Care Act and Medicaid. Other affordable drug policies, such as the $35 per month cap on insulin costs, were not ...